• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性尿道癌的治疗结果及预后因素

Outcomes and Prognostic Factors of Primary Urethral Cancer.

作者信息

Sui Wilson, RoyChoudhury Arindam, Wenske Sven, Decastro Guarionex J, McKiernan James M, Anderson Christopher B

机构信息

Department of Urology, Columbia University Medical Center, New York, NY.

Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY.

出版信息

Urology. 2017 Feb;100:180-186. doi: 10.1016/j.urology.2016.09.042. Epub 2016 Oct 5.

DOI:10.1016/j.urology.2016.09.042
PMID:27720774
Abstract

OBJECTIVE

To identify prognostic and treatment factors for primary urethral cancer using a nationwide database.

MATERIALS AND METHODS

The National Cancer Database was queried for all cases of primary urethral cancer from 2004 to 2013. Patients with other cancer diagnoses, metastasis, or diagnosis on autopsy were excluded. Proportional hazards regression was used to identify independent predictors of overall survival in patients with primary urethral cancer. Because we hypothesized that predictors may covary by sex, we also performed regression analysis stratified by sex.

RESULTS

We identified 1268 men and 869 women with primary urethral cancer. Women tended to have more advanced tumors and adenocarcinoma histology. Median survival for the entire cohort was 49 months (43-55), with 5- and 10-year survival rates of 46% and 31%, respectively. On multivariate analysis, age, race, stage, grade, and Charlson comorbidity index were independent predictors of overall survival. Histology was not a predictor of overall survival in the combined model; however, adenocarcinoma in women increased hazards of death, whereas it decreased hazards of death in men when compared with squamous cell carcinoma.

CONCLUSION

Men and women with primary urethral cancer had significant differences in histology, grade, and nodal status. In addition to several expected disease-related factors, black race was associated with increased mortality for patients with primary urethral cancer.

摘要

目的

利用全国性数据库确定原发性尿道癌的预后因素和治疗因素。

材料与方法

查询国家癌症数据库中2004年至2013年所有原发性尿道癌病例。排除有其他癌症诊断、转移或尸检诊断的患者。采用比例风险回归分析确定原发性尿道癌患者总生存的独立预测因素。由于我们假设预测因素可能因性别而异,因此我们还按性别进行了分层回归分析。

结果

我们确定了1268例男性和869例女性原发性尿道癌患者。女性往往有更晚期的肿瘤和腺癌组织学类型。整个队列的中位生存期为49个月(43 - 55个月),5年和10年生存率分别为46%和31%。多因素分析显示,年龄、种族、分期、分级和查尔森合并症指数是总生存的独立预测因素。在综合模型中,组织学不是总生存的预测因素;然而,与鳞状细胞癌相比,女性腺癌增加死亡风险,而男性腺癌降低死亡风险。

结论

原发性尿道癌男性和女性在组织学、分级和淋巴结状态方面存在显著差异。除了几个预期的疾病相关因素外,黑人种族与原发性尿道癌患者死亡率增加相关。

相似文献

1
Outcomes and Prognostic Factors of Primary Urethral Cancer.原发性尿道癌的治疗结果及预后因素
Urology. 2017 Feb;100:180-186. doi: 10.1016/j.urology.2016.09.042. Epub 2016 Oct 5.
2
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma.原发性尿道癌的预后因素及结局:原发性尿道癌国际协作研究结果
World J Urol. 2016 Jan;34(1):97-103. doi: 10.1007/s00345-015-1583-7. Epub 2015 May 17.
3
Nomograms for predicting long-term overall survival and cancer-specific survival in patients with primary urethral carcinoma: a population-based study.基于人群的原发性尿道癌患者长期总体生存和癌症特异性生存预测的列线图:一项基于人群的研究。
Int Urol Nephrol. 2020 Feb;52(2):287-300. doi: 10.1007/s11255-019-02314-y. Epub 2019 Oct 14.
4
Prognostic factors in male urethral cancer.男性尿道癌的预后因素。
Cancer. 2011 Jun 1;117(11):2426-34. doi: 10.1002/cncr.25787. Epub 2010 Dec 14.
5
The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer.种族/民族对尿道癌组织学亚型分布、初诊分期及癌症特异性生存的影响。
Urol Oncol. 2021 Jun;39(6):369.e9-369.e17. doi: 10.1016/j.urolonc.2020.11.031. Epub 2020 Dec 11.
6
Primary Female Urethral Carcinoma: Proposed Staging Modifications Based on Assessment of Female Urethral Histology and Analysis of a Large Series of Female Urethral Carcinomas.原发性女性尿道癌:基于女性尿道组织学评估和大量女性尿道癌分析的分期修改建议。
Am J Surg Pathol. 2020 Dec;44(12):1591-1601. doi: 10.1097/PAS.0000000000001569.
7
The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma.腹股沟淋巴结清扫术在男性尿道鳞状细胞癌中的作用。
Urol Oncol. 2018 Dec;36(12):526.e1-526.e6. doi: 10.1016/j.urolonc.2018.09.014. Epub 2018 Nov 13.
8
Primary tumor surgery improves survival in non-metastatic primary urethral carcinoma patients: a large population-based investigation.原发肿瘤手术可改善非转移性原发性尿道癌患者的生存:一项基于大样本的调查。
BMC Cancer. 2021 Jul 27;21(1):857. doi: 10.1186/s12885-021-08603-z.
9
Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis.女性尿道癌明确治疗后的预后因素和结局:基于人群的分析。
Urology. 2012 Aug;80(2):374-81. doi: 10.1016/j.urology.2012.02.058.
10
Conditional Survival in Anal Carcinoma Using the National Population-Based Survey of Epidemiology and End Results Database (1988-2012).利用基于全国人口的癌症流行病学和最终结果数据库(1988 - 2012年)分析肛管癌的条件生存率。
Dis Colon Rectum. 2016 Apr;59(4):291-8. doi: 10.1097/DCR.0000000000000555.

引用本文的文献

1
Primary signet ring cell carcinoma of the female urethra: A case report.女性尿道原发性印戒细胞癌:一例报告。
World J Clin Cases. 2025 Sep 26;13(27):107158. doi: 10.12998/wjcc.v13.i27.107158.
2
Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patients.原发性尿道癌:局限性、晚期和转移性患者的治疗模式、反应及生存情况
BJUI Compass. 2025 Jul 17;6(7):e70056. doi: 10.1002/bco2.70056. eCollection 2025 Jul.
3
Diagnosis of Female Urethral Cancer Based on Multimodal Ultrasound: A Case Report.
基于多模态超声的女性尿道癌诊断:一例报告
Int J Womens Health. 2025 Jun 11;17:1739-1744. doi: 10.2147/IJWH.S517310. eCollection 2025.
4
Effect of chemotherapy on cancer specific mortality in female locally advanced urethral cancer.化疗对女性局部晚期尿道癌癌症特异性死亡率的影响。
World J Urol. 2025 May 4;43(1):266. doi: 10.1007/s00345-025-05545-0.
5
Urethral clear cell adenocarcinoma in an adult female: A rare case report.成年女性尿道透明细胞腺癌:一例罕见病例报告。
Urol Case Rep. 2024 Nov 13;58:102882. doi: 10.1016/j.eucr.2024.102882. eCollection 2025 Jan.
6
Systematic Review of the Role of BCG in the Treatment of Urothelial Carcinoma of the Prostatic Urethra.卡介苗在前列腺尿道尿路上皮癌治疗中作用的系统评价
Bladder Cancer. 2021 May 25;7(2):213-220. doi: 10.3233/BLC-201516. eCollection 2021.
7
Disitamab Vedotin plus anti-PD-1 antibody show good efficacy in refractory primary urethral cancer with low HER2 expression: a case report.地昔他单抗维迪西妥单抗联合抗 PD-1 抗体治疗 HER2 低表达复发性原发性尿道癌的疗效良好:一例报告。
Front Immunol. 2023 Oct 12;14:1254812. doi: 10.3389/fimmu.2023.1254812. eCollection 2023.
8
Progress in the treatment of urethral adenocarcinoma.尿道腺癌的治疗进展
J Cancer Res Clin Oncol. 2023 Jun;149(6):2693-2698. doi: 10.1007/s00432-022-04481-5. Epub 2022 Nov 21.
9
A brief review on the diagnostic and therapeutic principles of primary urethral cancer.原发性尿道癌诊断与治疗原则简述
Asian J Urol. 2022 Oct;9(4):423-429. doi: 10.1016/j.ajur.2022.04.005. Epub 2022 Aug 23.
10
Chemotherapy combined with immunotherapy in primary female urethral squamous cell carcinoma: a case report.原发性女性尿道鳞癌化疗联合免疫治疗 1 例报告
J Int Med Res. 2022 Oct;50(10):3000605221132418. doi: 10.1177/03000605221132418.